| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Antiviral peptides against SARS-CoV-2: therapeutic targets, mechanistic antiviral activity, and efficient delivery
|
Essa, Raahilah Zahir
|
|
|
74 |
6 |
p. 1166-1181
|
artikel
|
| 2 |
Correction: Oral antiviral treatments for COVID-19: opportunities and challenges
|
Rahmah, Laila
|
|
|
74 |
6 |
p. 1326-1327
|
artikel
|
| 3 |
Correction: Real-world experience with molnupiravir during the period of SARS-CoV-2 Omicron variant dominance
|
Flisiak, Robert
|
|
|
74 |
6 |
p. 1328
|
artikel
|
| 4 |
Effects of L-carnitine supplementation in patients with mild-to-moderate COVID-19 disease: a pilot study
|
Talebi, Seyed Saman
|
|
|
74 |
6 |
p. 1296-1305
|
artikel
|
| 5 |
Efficacy of COVID-19 vaccines: a systematic review and network meta-analysis of phase 3 randomized controlled trials
|
Kumar, Subodh
|
|
|
74 |
6 |
p. 1228-1237
|
artikel
|
| 6 |
Health-related quality of life in survivors of severe COVID-19 infection
|
d’Ettorre, Gabriele
|
|
|
74 |
6 |
p. 1286-1295
|
artikel
|
| 7 |
Impact of SARS CoV-2 /COVID-19 infection on the course of advanced chronic liver disease and hepatocellular carcinoma
|
Pazgan-Simon, Monika
|
|
|
74 |
6 |
p. 1306-1314
|
artikel
|
| 8 |
Introduction to the special issue on “The Post-COVID Era: Advances and Challenges in Pharmacology”
|
Poręba, Marcin
|
|
|
74 |
6 |
p. 1118-1119
|
artikel
|
| 9 |
Jacareubin inhibits TLR4-induced lung inflammatory response caused by the RBD domain of SARS-CoV-2 Spike protein
|
Segura-Villalobos, Deisy
|
|
|
74 |
6 |
p. 1315-1325
|
artikel
|
| 10 |
Neurological consequences of COVID-19
|
Brola, Waldemar
|
|
|
74 |
6 |
p. 1208-1222
|
artikel
|
| 11 |
Note from editors
|
|
|
|
74 |
6 |
p. 1117
|
artikel
|
| 12 |
Oral antiviral treatments for COVID-19: opportunities and challenges
|
Rahmah, Laila
|
|
|
74 |
6 |
p. 1255-1278
|
artikel
|
| 13 |
Plant-derived immuno-adjuvants in vaccines formulation: a promising avenue for improving vaccines efficacy against SARS-CoV-2 virus
|
Kumar, Arbind
|
|
|
74 |
6 |
p. 1238-1254
|
artikel
|
| 14 |
Platelets in COVID-19 disease: friend, foe, or both?
|
Smęda, Marta
|
|
|
74 |
6 |
p. 1182-1197
|
artikel
|
| 15 |
Real-world experience with molnupiravir during the period of SARS-CoV-2 Omicron variant dominance
|
Flisiak, Robert
|
|
|
74 |
6 |
p. 1279-1285
|
artikel
|
| 16 |
Recent review of COVID-19 management: diagnosis, treatment and vaccination
|
Chavda, Vivek P.
|
|
|
74 |
6 |
p. 1120-1148
|
artikel
|
| 17 |
Short-chain fatty acids–microbiota crosstalk in the coronavirus disease (COVID-19)
|
Włodarczyk, Jakub
|
|
|
74 |
6 |
p. 1198-1207
|
artikel
|
| 18 |
The roles of cellular protease interactions in viral infections and programmed cell death: a lesson learned from the SARS-CoV-2 outbreak and COVID-19 pandemic
|
Majchrzak, Martyna
|
|
|
74 |
6 |
p. 1149-1165
|
artikel
|
| 19 |
To aspirate or not to aspirate? Considerations for the COVID-19 vaccines
|
Rzymski, Piotr
|
|
|
74 |
6 |
p. 1223-1227
|
artikel
|
Tijdschrift beschrijving